Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ responseSeddigheh Razani-Boroujerdi, R Thomas Boyd, Martha I Dávila-García, et al.
Nature Communications|February 15, 2017
A metamorphic inorganic framework that can be switched between eight single-crystalline statesCaihong Zhan, Jamie M Cameron, David Gabb, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2010
Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptorsBrandon J Henderson, Ryan E Pavlovicz, Jerad D Allen, et al.
Investigational New Drugs|August 23, 2018
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphomaTycel Phillips, Paul M Barr, Steven I Park, et al.
Blood|December 8, 2009
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphomaNicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2008
Effect of novel negative allosteric modulators of neuronal nicotinic receptors on cells expressing native and recombinant nicotinic receptors: implications for drug discoveryTatiana F González-Cestari, Brandon J Henderson, Ryan E Pavlovicz, et al.
Cancer|January 10, 2019
A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinomaSumanta K Pal, Andres Forero-Torres, John A Thompson, et al.
Lancet (London, England)|April 18, 2015
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trialPeter Hillmen, Tadeusz Robak, Ann Janssens, et al.
Psychopharmacology|August 10, 2006
Guidelines on nicotine dose selection for in vivo researchShannon G Matta, David J Balfour, Neal L Benowitz, et al.
Pageof 4